- Home
- QMCO vs IMRN Comparison
QMCO vs IMRN Comparison
Compare QMCO & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- IMRN
- Stock Information
- Founded
- QMCO 1980
- IMRN 1994
- Country
- QMCO United States
- IMRN Australia
- Employees
- QMCO N/A
- IMRN N/A
- Industry
- QMCO Electronic Components
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- QMCO Technology
- IMRN Health Care
- Exchange
- QMCO Nasdaq
- IMRN Nasdaq
- Market Cap
- QMCO 15.4M
- IMRN 15.0M
- IPO Year
- QMCO N/A
- IMRN N/A
- Fundamental
- Price
- QMCO $3.47
- IMRN $2.69
- Analyst Decision
- QMCO Hold
- IMRN Strong Buy
- Analyst Count
- QMCO 1
- IMRN 1
- Target Price
- QMCO N/A
- IMRN $5.00
- AVG Volume (30 Days)
- QMCO 33.6K
- IMRN 5.7K
- Earning Date
- QMCO 10-15-2024
- IMRN 10-15-2024
- Dividend Yield
- QMCO N/A
- IMRN N/A
- EPS Growth
- QMCO N/A
- IMRN N/A
- EPS
- QMCO N/A
- IMRN N/A
- Revenue
- QMCO $290,448,000.00
- IMRN $3,271,194.00
- Revenue This Year
- QMCO N/A
- IMRN N/A
- Revenue Next Year
- QMCO $0.11
- IMRN N/A
- P/E Ratio
- QMCO N/A
- IMRN N/A
- Revenue Growth
- QMCO N/A
- IMRN 171.67
- 52 Week Low
- QMCO $2.22
- IMRN $1.48
- 52 Week High
- QMCO $18.00
- IMRN $5.96
- Technical
- Relative Strength Index (RSI)
- QMCO 43.83
- IMRN 51.76
- Support Level
- QMCO $3.22
- IMRN $2.66
- Resistance Level
- QMCO $3.60
- IMRN $2.87
- Average True Range (ATR)
- QMCO 0.24
- IMRN 0.11
- MACD
- QMCO 0.13
- IMRN 0.00
- Stochastic Oscillator
- QMCO 49.34
- IMRN 54.85
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.